Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Resources Shenlu Pharmaceutical Co., Ltd. is a specialized pharmaceutical manufacturer based in Hefei, China, and operates as a key subsidiary of China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. The company focuses on the research, development, and production of Traditional Chinese Medicine (TCM) and health supplements, primarily under the well-established 'Shenlu' brand. Its core product portfolio includes Bupi Yishen Granules, which are widely used for the treatment of chronic kidney disease, alongside various oral liquids and capsules for general health and digestive support. The company operates modern, GMP-certified manufacturing facilities that integrate traditional herbal processing with contemporary pharmaceutical technology. As part of the broader China Resources Group, it plays a significant role in the modernization and commercialization of TCM within the Chinese healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Resources Shenlu Pharmaceutical.